|
DTNB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.916800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.281700E-03 |
| Normal-vs-Stage2 |
1.320210E-01 |
| Normal-vs-Stage3 |
7.375400E-01 |
| Normal-vs-Stage4 |
1.476560E-01 |
| Stage1-vs-Stage2 |
5.587800E-01 |
| Stage1-vs-Stage3 |
8.405600E-02 |
| Stage1-vs-Stage4 |
2.436100E-02 |
| Stage2-vs-Stage3 |
3.403600E-01 |
| Stage2-vs-Stage4 |
4.279500E-02 |
| Stage3-vs-Stage4 |
1.911810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.843500E-03 |
| Normal-vs-AfricanAmerican |
4.214400E-02 |
| Normal-vs-Asian |
7.454200E-01 |
| Caucasian-vs-AfricanAmerican |
9.890000E-01 |
| Caucasian-vs-Asian |
8.680600E-01 |
| AfricanAmerican-vs-Asian |
8.069000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.030190E-02 |
| Normal-vs-Female |
4.224600E-03 |
| Male-vs-Female |
2.334800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.039400E-01 |
| Normal-vs-Extreme_Weight |
6.378800E-03 |
| Normal-vs-Obese |
8.061500E-03 |
| Normal-vs-Extreme_Obese |
6.501800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.372000E-01 |
| Normal_Weight-vs-Obese |
2.044000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.855400E-01 |
| Extreme_Weight-vs-Obese |
7.909000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.124400E-01 |
| Obese-vs-Extreme_Obese |
2.967200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.787200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.444800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.195400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.460400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.459000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.524000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.651400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.000400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.593200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.863400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01710000000033E-06 |
| Normal-VS-Type2 PRCC |
4.246800E-01 |
| Normal-VS-KIRP CIMP |
7.888800E-01 |
| Normal-VS-Unclassified PRCC |
5.513900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.36959999692033E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.240700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.289600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.273600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.613580E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.619810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.296000E-01 |
| Normal-vs-N1 |
8.764200E-01 |
| Normal-vs-N2 |
4.719400E-01 |
| N0-vs-N1 |
7.295200E-01 |
| N0-vs-N2 |
4.605000E-01 |
| N1-vs-N2 |
5.429400E-01 |
|
|
